E-LIB Suche - Ergebnisse für: Phillips, Patrick P. J.

1

Estimands for clinical endpoints in tuberculosis treatment ..:

Weir, Isabelle R. ; Dufault, Suzanne M. ; Phillips, Patrick P. J.
Trials. 25 (2024) 1 - p. , 2024

2

Tuberculosis treatment monitoring tests during routine prac..:

MacLean, Emily Lai-Ho ; Zimmer, Alexandra J. ; den Boon, Saskia...
Clinical Microbiology and Infection. 30 (2024) 4 - p. 481-488 , 2024

Link: https://doi.org/10.1016/..

3

Evaluation of the Xpert MTB Host Response assay for the tri..:

Gupta-Wright, Ankur ; Ha, Huy ; Abdulgadar, Shima...
The Lancet Global Health. 12 (2024) 2 - p. e226-e234 , 2024

Link: https://doi.org/10.1016/..

4

Treatment-shortening regimens for tuberculosis: updates and..:

Saluzzo, Francesca ; Adepoju, Victor Abiola ; Duarte, Raquel..
Breathe. 19 (2023) 3 - p. 230028 , 2023

Link: https://doi.org/10.1183/..

5

Drug interaction potential of high-dose rifampicin in patie..:

Stemkens, Ralf ; Jager, Veronique de ; Dawson, Rodney...
Antimicrobial Agents and Chemotherapy. 67 (2023) 10 - p. , 2023

Link: https://doi.org/10.1128/..

6

Early bactericidal activity studies for pulmonary tuberculo..:

Koele, Simon E. ; Phillips, Patrick P.J. ; Upton, Caryn M....
International Journal of Antimicrobial Agents. 61 (2023) 5 - p. 106775 , 2023

Link: https://doi.org/10.1016/..

7

Protocol for a feasibility randomized controlled trial to e..:

Mpagama, Stellah G. ; Mvungi, Happiness C. ; Mbelele, Peter M....
Pilot and Feasibility Studies. 9 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

8

A flexible multi‐metric Bayesian framework for decision‐mak..:

Dufault, Suzanne M. ; Crook, Angela M. ; Rolfe, Katie.
Statistics in Medicine. 43 (2023) 3 - p. 501-513 , 2023

Link: https://doi.org/10.1002/..

9

MOVER approximated CV: A tool for quantifying precision in ..:

Dide-Agossou, Christian ; Rossmassler, Karen ; Reid, Justin...
Journal of Pharmaceutical and Biomedical Analysis. 212 (2022) - p. 114664 , 2022

Link: https://doi.org/10.1016/..

10

Rifapentine With and Without Moxifloxacin for Pulmonary Tub..:

Pettit, April C ; Phillips, Patrick P J ; Kurbatova, Ekaterina...
Clinical Infectious Diseases. 76 (2022) 3 - p. e580-e589 , 2022

Link: https://doi.org/10.1093/..

11

Tuberculosis screening improves preventive therapy uptake (..:

Semitala, Fred C. ; Chaisson, Lelia H. ; Dowdy, David W....
Trials. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

12

Efavirenz Pharmacokinetics and Human Immunodeficiency Virus..:

Podany, Anthony T ; Pham, Michelle ; Sizemore, Erin...
Clinical Infectious Diseases. 75 (2021) 4 - p. 560-566 , 2021

Link: https://doi.org/10.1093/..

13

Completion of isoniazid–rifapentine (3HP) for tuberculosis ..:

Semitala, Fred C. ; Kadota, Jillian L. ; Musinguzi, Allan...
PLOS Medicine. 18 (2021) 12 - p. e1003875 , 2021

Link: https://doi.org/10.1371/..

14

Increased bactericidal activity but dose-limiting intolerab..:

te Brake, Lindsey H.M. ; de Jager, Veronique ; Narunsky, Kim...
European Respiratory Journal. 58 (2021) 1 - p. 2000955 , 2021

Link: https://doi.org/10.1183/..

15

Protocol for the 3HP Options Trial: a hybrid type 3 impleme..:

Kadota, Jillian L. ; Musinguzi, Allan ; Nabunje, Juliet...
Implementation Science. 15 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..